This topic contains a solution. Click here to go to the answer

Author Question: Alosetron is approved for which population? 1. Women with diarrhea-predominant IBS 2. Men with ... (Read 25 times)

tichca

  • Hero Member
  • *****
  • Posts: 554
Alosetron is approved for which population?
 
  1. Women with diarrhea-predominant IBS
  2. Men with constipation and crampy abdominal pain
  3. Pregnant women with iron-associated constipation
  4. Children whose growth rate is reduced because of IBS

Question 2

Tegaserod should not be administered to patients with:
 
  1. severe renal impairment.
  2. constipation.
  3. sulfa allergy.
  4. weight gain.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

annierak

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

Correct Answer: 1

Answer to Question 2

Correct Answer: 1




tichca

  • Member
  • Posts: 554
Reply 2 on: Jul 23, 2018
Wow, this really help


blakcmamba

  • Member
  • Posts: 335
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

It is believed that the Incas used anesthesia. Evidence supports the theory that shamans chewed cocoa leaves and drilled holes into the heads of patients (letting evil spirits escape), spitting into the wounds they made. The mixture of cocaine, saliva, and resin numbed the site enough to allow hours of drilling.

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

According to the National Institute of Environmental Health Sciences, lung disease is the third leading killer in the United States, responsible for one in seven deaths. It is the leading cause of death among infants under the age of one year.

For a complete list of videos, visit our video library